par 210 par 210 (Propafenone Extended Release 325 mg)

Pill imprint par 210 par 210 has been identified as Propafenone hydrochloride extended release 325 mg.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substance Act (CSA).

Propafenone hydrochloride extended release

Imprint:

par 210 par 210

Strength:

325 mg

Color:

Orange & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Group I antiarrhythmics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Par Pharmaceutical Inc

National Drug Code (NDC):

49884-0210

Inactive Ingredients:

lactose anhydrous
magnesium stearate
povidone
FD&C Blue No. 1
gelatin
titanium dioxide
D&C Yellow No. 10
ferrosoferric oxide
butyl alcohol
propylene glycol
FD&C Blue No. 2
FD&C Red No. 40
shellac
alcohol
water
ethylcelluloses

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0917	Amerisource Health Services
42291-0546	AvKare, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.